WallStreetZenWallStreetZen

NASDAQ: BPMC
Blueprint Medicines Corp Stock Forecast, Predictions & Price Target

Analyst price target for BPMC

Based on 13 analysts offering 12 month price targets for Blueprint Medicines Corp.
Min Forecast
$88.00-2.98%
Avg Forecast
$126.85+39.85%
Max Forecast
$168.00+85.23%

Should I buy or sell BPMC stock?

Based on 13 analysts offering ratings for Blueprint Medicines Corp.
Buy
Strong Buy
4 analysts 30.77%
Buy
5 analysts 38.46%
Hold
4 analysts 30.77%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BPMC stock forecasts and price targets.

BPMC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-10-31
lockedlocked$00.00+00.00%2024-10-31
lockedlocked$00.00+00.00%2024-10-31
lockedlocked$00.00+00.00%2024-10-24
lockedlocked$00.00+00.00%2024-08-02
Baird
Top 19%
82
BuyMaintains$127.00+40.02%2024-08-02
Barclays
Top 39%
62
HoldMaintains$105.00+15.77%2024-07-29
Morgan Stanley
Top 8%
93
HoldMaintains$115.00+26.79%2024-07-12
Oppenheimer
Bottom 5%
5
BuyMaintains$125.00+37.82%2024-07-08
JMP Securities
Top 15%
86
BuyReiterates$125.00+37.82%2024-06-07

1 of 2

Forecast return on equity

Is BPMC forecast to generate an efficient return?
Company
88%
Industry
151.03%
Market
74.09%
BPMC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BPMC forecast to generate an efficient return on assets?
Company
22.97%
Industry
25.6%
BPMC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BPMC earnings per share forecast

What is BPMC's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$3.65
Avg 2 year Forecast
-$1.56
Avg 3 year Forecast
$1.48

BPMC revenue forecast

What is BPMC's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$506.1M+16.5%
Avg 2 year Forecast
$691.9M+59.28%
Avg 3 year Forecast
$917.2M+111.14%
BPMC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BPMC revenue growth forecast

How is BPMC forecast to perform vs Biotechnology companies and vs the US market?
Company
27.98%
Industry
36.91%
Market
9.44%
BPMC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BPMC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BPMC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BPMC$90.70$126.85+39.85%Buy
NUVL$89.22$116.00+30.02%Strong Buy
IONS$38.76$61.31+58.17%Buy
CYTK$51.82$81.27+56.84%Buy
KRYS$176.39$211.80+20.07%Buy

Blueprint Medicines Stock Forecast FAQ

Is Blueprint Medicines Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NASDAQ: BPMC) stock is to Buy BPMC stock.

Out of 13 analysts, 4 (30.77%) are recommending BPMC as a Strong Buy, 5 (38.46%) are recommending BPMC as a Buy, 4 (30.77%) are recommending BPMC as a Hold, 0 (0%) are recommending BPMC as a Sell, and 0 (0%) are recommending BPMC as a Strong Sell.

If you're new to stock investing, here's how to buy Blueprint Medicines stock.

What is BPMC's earnings growth forecast for 2024-2026?

(NASDAQ: BPMC) Blueprint Medicines's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.69%.

Blueprint Medicines's earnings in 2024 is -$128,050,000.On average, 6 Wall Street analysts forecast BPMC's earnings for 2024 to be -$231,551,680, with the lowest BPMC earnings forecast at -$252,197,577, and the highest BPMC earnings forecast at -$222,340,433. On average, 11 Wall Street analysts forecast BPMC's earnings for 2025 to be -$99,271,827, with the lowest BPMC earnings forecast at -$161,355,629, and the highest BPMC earnings forecast at -$33,033,436.

In 2026, BPMC is forecast to generate $93,808,605 in earnings, with the lowest earnings forecast at $635,258 and the highest earnings forecast at $238,221,893.

What is BPMC's revenue growth forecast for 2024-2026?

(NASDAQ: BPMC) Blueprint Medicines's forecast annual revenue growth rate of 27.98% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.91%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.44%.

Blueprint Medicines's revenue in 2024 is $434,414,000.On average, 9 Wall Street analysts forecast BPMC's revenue for 2024 to be $32,148,901,992, with the lowest BPMC revenue forecast at $30,245,921,989, and the highest BPMC revenue forecast at $33,203,049,747. On average, 9 Wall Street analysts forecast BPMC's revenue for 2025 to be $43,954,543,726, with the lowest BPMC revenue forecast at $38,814,922,276, and the highest BPMC revenue forecast at $47,777,782,760.

In 2026, BPMC is forecast to generate $58,266,216,243 in revenue, with the lowest revenue forecast at $50,701,877,083 and the highest revenue forecast at $67,407,266,702.

What is BPMC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BPMC) forecast ROA is 22.97%, which is lower than the forecast US Biotechnology industry average of 25.6%.

What is BPMC's Price Target?

According to 13 Wall Street analysts that have issued a 1 year BPMC price target, the average BPMC price target is $126.85, with the highest BPMC stock price forecast at $168.00 and the lowest BPMC stock price forecast at $88.00.

On average, Wall Street analysts predict that Blueprint Medicines's share price could reach $126.85 by Oct 31, 2025. The average Blueprint Medicines stock price prediction forecasts a potential upside of 39.85% from the current BPMC share price of $90.70.

What is BPMC's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: BPMC) Blueprint Medicines's current Earnings Per Share (EPS) is -$2.06. On average, analysts forecast that BPMC's EPS will be -$3.65 for 2024, with the lowest EPS forecast at -$3.97, and the highest EPS forecast at -$3.50. On average, analysts forecast that BPMC's EPS will be -$1.56 for 2025, with the lowest EPS forecast at -$2.54, and the highest EPS forecast at -$0.52. In 2026, BPMC's EPS is forecast to hit $1.48 (min: $0.01, max: $3.75).

What is BPMC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BPMC) forecast ROE is 88%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.